The goal of this clinical trial is to learn if an immersive virtual reality (VR) exercise program can help reduce back pain and improve physical function and psychological well-being in adults with chronic low back pain. The main questions it aim to answer are * Does the virtual reality (VR) exercise reduce back pain? * Does it lead to positive changes in how participants perceive pain? * Does it improve back flexibility and reduce disability in daily activities? * Does it help reduce the fear of movement and negative thoughts related to pain? Method Wear a Meta Quest 3s device and participate in a 15-minute virtual reality exercise program called 'FitXR'. Be evaluated for their back pain, sensory test, range of motion, and level of disability in daily life before and after the exercise program. Complete questionnaires about their thoughts and feelings regarding their pain and movement.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
participants assigned to the intervention group will perform a 15-minute immersive virtual reality (VR) exercise program using the FitXR application on the Meta Quest 3s headset. This program provides interactive, visually immersive exercise tasks designed to engage participants in physical activity while reducing fear of movement and enhancing functional recovery.
Participants assigned to this arm will perform the same 15-minute exercise program without virtual reality equipment. This allows comparison between immersive VR-based exercise and conventional exercise of equivalent intensity and duration.
Sahmyook University, Science Hall 3
Seoul, Seoul, South Korea
Quantitative Sensory Testing (QST): Specifically including Conditioned Pain Modulation (CPM) and Temporal Summation (TS) protocols.
CPM measures the efficiency of the body's pain-inhibiting pathways. A higher positive value indicates a more effective pain modulation system (better outcome). TS measures pain sensitization. A higher score indicates greater central sensitization to pain (worse outcome).
Time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).
Tampa Scale for Kinesiophobia-13 (TSK-13)
The scale scores range from 13 to 52. A higher score indicates a greater degree of kinesiophobia (fear of movement), which is a worse outcome.
Time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).
Pain Catastrophizing Scale (PCS)
The scale score ranges from 0 to 52. A higher score indicates a greater level of pain catastrophizing (a worse outcome).
Time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).
Oswestry Disability Index (ODI)
This index measures disability due to low back pain, with the score reported as a percentage from 0% to 100%. A score of 0% indicates no disability, while 100% indicates the most severe disability (a worse outcome).
Time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).
Fear-Avoidance Beliefs Questionnaire (FABQ)
This questionnaire has two subscales: Physical Activity (range 0-24) and Work (range 0-42). For both scales, a higher score indicates stronger fear-avoidance beliefs (a worse outcome).
Time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).
Visual Analog Scale (VAS)
This scale measures the intensity of pain. It is typically a 100-millimeter line on which participants mark their pain level. A score of 0 mm indicates "no pain", while 100 mm indicates "the worst pain imaginable". A lower score represents a better outcome.
Time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).
Lumbar Range of Motion (ROM)
This is a physical measurement of lumbar spine flexibility, objectively assessed using a dual inclinometer. The range of motion for flexion, lateral bending is reported in degrees (°). A higher value, representing a greater range of movement, indicates better physical function (a better outcome).
Time frame: Measured at Week 1 (baseline), Week 6 (post-intervention), and Week 8 (follow-up).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.